Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Pierre Fabre Pharma Norden AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 208,091 More Arrow 242,913 Less Arrow 207,807
Financial expenses 345 More Arrow 581 Less Arrow 285
Earnings before taxes 6,359 More Arrow 8,056 Less Arrow 5,799
EBITDA 6,078 More Arrow 8,857 Less Arrow 6,173
Total assets 156,766 Less Arrow 130,312 More Arrow 145,289
Current assets 155,859 Less Arrow 129,384 More Arrow 144,241
Current liabilities 132,579 Less Arrow 105,053 More Arrow 125,637
Equity capital 24,187 More Arrow 25,259 Less Arrow 19,652
- share capital 400 Equal arrow 400 Equal arrow 400
Employees (average) 16 Less Arrow 15 Less Arrow 14

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 15.4% More Arrow 19.4% Less Arrow 13.5%
Turnover per employee 13,006 More Arrow 16,194 Less Arrow 14,843
Profit as a percentage of turnover 3.1% More Arrow 3.3% Less Arrow 2.8%
Return on assets (ROA) 4.3% More Arrow 6.6% Less Arrow 4.2%
Current ratio 117.6% More Arrow 123.2% Less Arrow 114.8%
Return on equity (ROE) 26.3% More Arrow 31.9% Less Arrow 29.5%
Change turnover -34,822 More Arrow 35,106 Less Arrow 20,715
Change turnover % -14% More Arrow 17% Less Arrow 11%
Chg. No. of employees 1 Equal arrow 1 Equal arrow 1
Chg. No. of employees % 7% Equal arrow 7% More Arrow 8%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.